Next Article in Journal
Acknowledgment to Reviewers of Molbank in 2020
Previous Article in Journal
Short Note


Ashburn Group, Mathematics, Natural, and Health Sciences Division, University of Hawai‘i West O‘ahu, 91-1001 Farrington Hwy, Kapolei, HI 96707, USA
Author to whom correspondence should be addressed.
Academic Editor: Fawaz Aldabbagh
Molbank 2021, 2021(1), M1184;
Received: 8 December 2020 / Revised: 19 January 2021 / Accepted: 21 January 2021 / Published: 25 January 2021
(This article belongs to the Section Organic Synthesis)
Natural products known as chalcones show promise as chemotherapeutic agents for the neglected tropical disease known as leishmaniasis. Our objective is to synthesize new targets of opportunity that may lead to better treatments of this debilitating disease. Claisen-Schmidt condensation of 4-chlorobenzaldehyde with 2′-fluoro-4′-methoxyacetophenone using aqueous sodium hydroxide in ethanol yielded the novel compound (E)-3-(4-chlorophenyl)-1-(2-fluoro-4-methoxyphenyl)-2-propen-1-one. The product was obtained in good yield and purity after recrystallization from ethyl acetate/hexane. With the known antiparasitic properties of halogenated chalcones, this novel compound is suitable for antileishmanial activity study. View Full-Text
Keywords: chalcone; synthesis; aldol; leishmaniasis; neglected tropical disease chalcone; synthesis; aldol; leishmaniasis; neglected tropical disease
Show Figures

Figure 1

MDPI and ACS Style

Bailey, N.; Atanes, A.; Ashburn, B.O. (E)-3-(4-Chlorophenyl)-1-(2-fluoro-4-methoxyphenyl)-2-propen-1-one. Molbank 2021, 2021, M1184.

AMA Style

Bailey N, Atanes A, Ashburn BO. (E)-3-(4-Chlorophenyl)-1-(2-fluoro-4-methoxyphenyl)-2-propen-1-one. Molbank. 2021; 2021(1):M1184.

Chicago/Turabian Style

Bailey, Nicholas, Alaina Atanes, and Bradley O. Ashburn. 2021. "(E)-3-(4-Chlorophenyl)-1-(2-fluoro-4-methoxyphenyl)-2-propen-1-one" Molbank 2021, no. 1: M1184.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop